Drug Profile
Pamapimod - Kinarus AG
Alternative Names: R-1503; RO-4402257Latest Information Update: 13 Oct 2022
Price :
$50
*
At a glance
- Originator Roche
- Class Antirheumatics; Pyridones; Pyrimidines
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis